Respiratory Syncytial Virus-A in Severe Acute Respiratory Syndrome Coronavirus-2-Negative Pediatric Patients: Insights from Tertiary Healthcare Center in Pune.

IF 0.7 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Indian journal of public health Pub Date : 2025-07-01 Epub Date: 2025-10-04 DOI:10.4103/ijph.ijph_61_24

Manasi V Chavan, Prachi V Prasad, Avinash A Lendave, Chandrashekhar G Raut, Abhilasha J Bhawalkar

{"title":"Respiratory Syncytial Virus-A in Severe Acute Respiratory Syndrome Coronavirus-2-Negative Pediatric Patients: Insights from Tertiary Healthcare Center in Pune.","authors":"Manasi V Chavan, Prachi V Prasad, Avinash A Lendave, Chandrashekhar G Raut, Abhilasha J Bhawalkar","doi":"10.4103/ijph.ijph_61_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Summary: </strong>The global impact of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has raised concerns regarding the potential risk of respiratory viruses in children. Although respiratory syncytial virus (RSV) and SARS-CoV-2 exhibit similar clinical manifestations, the detection of RSV has decreased. Therefore, we aimed to evaluate the role of RSV in pediatric cases that tested negative for SARS-CoV-2. A total of 106 cases, aged 4 days-18 years, from October 1, 2021, to March 31, 2022, were tested for RSV-A using polymerase chain reaction (PCR). Samples were tested for RSV-A using conventional PCR. RSV-A was detected in 34% of cases with the highest prevalence (25.5%) in school-going children aged 6-12 years. This reinforces the significance of RSV-A as a prevalent viral pathogen among young children. These results highlight the importance of preventive measures and/or efficient antiviral medication to lower the illness load in young infants.</p>","PeriodicalId":13298,"journal":{"name":"Indian journal of public health","volume":"69 3","pages":"335-337"},"PeriodicalIF":0.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of public health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/ijph.ijph_61_24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/4 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Summary: The global impact of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has raised concerns regarding the potential risk of respiratory viruses in children. Although respiratory syncytial virus (RSV) and SARS-CoV-2 exhibit similar clinical manifestations, the detection of RSV has decreased. Therefore, we aimed to evaluate the role of RSV in pediatric cases that tested negative for SARS-CoV-2. A total of 106 cases, aged 4 days-18 years, from October 1, 2021, to March 31, 2022, were tested for RSV-A using polymerase chain reaction (PCR). Samples were tested for RSV-A using conventional PCR. RSV-A was detected in 34% of cases with the highest prevalence (25.5%) in school-going children aged 6-12 years. This reinforces the significance of RSV-A as a prevalent viral pathogen among young children. These results highlight the importance of preventive measures and/or efficient antiviral medication to lower the illness load in young infants.

查看原文本刊更多论文

严重急性呼吸综合征冠状病毒2阴性患儿的呼吸道合胞病毒a：来自浦那三级医疗中心的见解

摘要：严重急性呼吸综合征冠状病毒-2 （SARS-CoV-2）的全球影响引发了人们对儿童呼吸道病毒潜在风险的担忧。虽然呼吸道合胞病毒（RSV）和SARS-CoV-2表现出相似的临床表现，但RSV的检出率有所下降。因此，我们旨在评估RSV在SARS-CoV-2检测阴性的儿科病例中的作用。采用聚合酶链反应（PCR）检测了2021年10月1日至2022年3月31日106例年龄为4天至18岁的RSV-A。用常规PCR检测样本的RSV-A。在34%的病例中检测到RSV-A，其中6-12岁学龄儿童的患病率最高（25.5%）。这加强了RSV-A作为幼儿中流行的病毒病原体的重要性。这些结果强调了预防措施和/或有效的抗病毒药物对降低幼儿疾病负担的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Indian journal of public health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

2.40

自引率

0.00%

发文量

审稿时长

21 weeks

期刊介绍： Indian Journal of Public Health is a peer-reviewed international journal published Quarterly by the Indian Public Health Association. It is indexed / abstracted by the major international indexing systems like Index Medicus/MEDLINE, SCOPUS, PUBMED, etc. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles. The Indian Journal of Public Health publishes articles of authors from India and abroad with special emphasis on original research findings that are relevant for developing country perspectives including India. The journal considers publication of articles as original article, review article, special article, brief research article, CME / Education forum, commentary, letters to editor, case series reports, etc. The journal covers population based studies, impact assessment, monitoring and evaluation, systematic review, meta-analysis, clinic-social studies etc., related to any domain and discipline of public health, specially relevant to national priorities, including ethical and social issues. Articles aligned with national health issues and policy implications are prefered.